Good news from the ATTLAS trial for pa... - Lung Cancer Support

Lung Cancer Support

4,002 members2,170 posts

Good news from the ATTLAS trial for patients with EGFR mutations and ALK translocations.

Denzie profile image
DenzieModeratorVolunteer
0 Replies

Treatment with atezolizumab, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin

dailynews.ascopubs.org/do/a...

Written by
Denzie profile image
Denzie
Moderator
To view profiles and participate in discussions please or .
Read more about...

You may also like...

EGFR mutations on exon 20 and exon 21

I have EGFR S768I (exon 20) and EGFR L858R (exon 21) mutations. Is it normal to have more than one...

Good news - Stage IIIB

good news. I have had clear scan results today after being diagnosed with Stage IIIB, non small...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

immunotherapy option for NSCLC gives patients more options for first line treatments than ever...

Got some good news today

Sharing the good news of my scan results